Patient navigation program for cervical cancer screening in Senegal
Adaptation and Implementation of a Patient Navigation Program for Cervical Cancer Screening Across Contexts in Senegal
This study is testing a new support program to help women in Senegal get screened for cervical cancer and access treatment more easily.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 901 (estimated) |
| Ages | 25 Years to 69 Years |
| Sex | All |
| Sponsor | University of Illinois at Chicago Academic / other |
| Locations | 1 site (Dakar) |
| Trial ID | NCT05544084 on ClinicalTrials.gov |
What this trial studies
This project aims to prevent cervical cancer deaths in Senegal by addressing barriers to screening and treatment among women. Using a mixed methods approach, the study will adapt an evidence-based patient navigation program to fit both urban and rural contexts in Senegal. The Dynamic Adaptation Process will be employed to evaluate the program's effectiveness and implementation outcomes. The study will involve a stepped-wedge randomized pragmatic trial to assess the impact of navigation services on screening rates and treatment access.
Who should consider this trial
Good fit: Ideal candidates include Senegalese citizens aged 25 to 69 who are willing to participate in survey assessments and seek cervical cancer prevention services.
Not a fit: Patients who are not citizens of Senegal or those outside the specified age range may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly increase cervical cancer screening rates and improve treatment access for women in Senegal.
How similar studies have performed: Other studies have shown success with patient navigation programs in improving cancer screening rates, indicating a promising approach for this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: The inclusion criteria for samples a, b, \& c are as follows: 1\) Senegal citizen between the ages of 25 and 69, 2) willing to participate in survey assessments; The additional criteria apply for both women and men for the follow samples: Sample a: 3) an invited member of the study National Advisory Board or Regional Implementation Resource Teams as defined above; 4) able to read and write in French. Sample b: 3) employed by the state at a study site health facility as a patient navigator, clinician (nurse, midwife) who treats and educates patients, or is a community health worker at the facility or community level (Bajenu Gox - women's health educator). Sample c: Women: 3) a woman living with a male partner who also agrees to participate in the study, 4) eligible to seek cervical cancer prevention services at a designated health facility in Senegal. Men: 3) a man living in a household with at least one woman eligible to seek cervical cancer prevention services at a designated health facility in Senegal. Exclusion Criteria: * No additional exclusion criteria exist.
Where this trial is running
Dakar
- University of Cheikh Anta Diop, Institute of Health and Development — Dakar, Senegal (Recruiting)
Study contacts
- Principal investigator: Jon A Dykens, MD, MPH — University of Illinois at Chicago
- Study coordinator: Jon A Dykens, MD, MPH
- Email: jdykens@uic.edu
- Phone: 573-355-0452
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.